Genomtec SA

Genomtec is a MedTech company founded in 2016 with the slogan "Molecular diagnosis everywhere, at the right time and for the right price." The company specializes in advanced technologies for genetic diagnostics. Their flagship project, the Genomtec ID mobile diagnostic system, holds EU CE-IVD certification for the Genomtec ID RP5-PLEX diagnostic panel, enabling fast and precise molecular analysis for common respiratory tract infections. The technology, protected by 11 patents and over 35 pending applications across global markets, utilizes microfluidic and proprietary patented SNAAT® isothermal technology. With a focus on biotechnology and healthcare, Genomtec is headquartered in Wroclaw, Poland and has a branch in the UK. Their second project, "OncoSNAAT," aims to develop automated mutation detection technology for clinical oncology utilizing lab-on-chip solutions. The company has recently received a PLN21.60M grant investment on 29th December 2023 from the Polish Agency for Enterprise Development. Genomtec's team comprises experienced individuals from various fields, combining confidence in molecular diagnostics with simplicity and cost reduction. With a passion for creation, the company works with young, ambitious scientists and constructors, alongside seasoned experts in commercialization and effective market strategies.